XTAMPZA

Collegium Pharmaceutical, Inc.🇺🇸 United States

FDA Page

Effective Date: Dec 20, 2023
Approval ID: b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c
Products: 5 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XTAMPZA ER safely and effectively. See full prescribing information for XTAMPZA ER. XTAMPZA ER (oxycodone) extended-release capsules, for oral use, CII Initial U.S. Approval: 1950

Quick Stats

Total Products5

Labelers2

Label Sections26

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.